Found 82 matching trials
PSMA and TARP Peptide Vaccine With Poly IC-LC Adjuvant in HLA-A2 (+) Patients With Elevated PSA After Initial Definitive Treatment NA Pilot Immunotherapy Study of Combination Prostate Specific Membrane Antigen...
Show More Location
H. Lee Moffitt Cancer Center & Research Institute
Learn More & Join Trial
Neoepitope-based Personalized Vaccine Approach in Patients With Newly Diagnosed Glioblastoma PHASE1 The early clinical development paradigm for chemotherapeutic agents has sig...
Show More Location
Washington University School of Medicine
Learn More & Join Trial
A Pilot Study of Glioma Associated Antigen Vaccines in Conjunction with Poly-ICLC in Pediatric Gliomas PHASE1 The overall objective of this pilot study is to collect immunological and s...
Show More Location
Children's Hospital of Pittsburgh of UPMC
Learn More & Join Trial
Personalized Neoantigen Peptide Vaccines for Solid Tumors PHASE1 This clinical trial is studying the safety and efficacy of a personalized c...
Show More Location
Horizon Cancer Excellence Center, Bumrungrad International Hospital
Learn More & Join Trial
Clinical Study for the Safety and Therapeutic Efficacy of the AI-QMMM Designed TamavaqTM Personalised Vaccine in Patients With Newly Diagnosed Glioma. EARLY_PHASE1 Gliomas are a heterogeneous group of tumors arising from glial cells in the...
Show More Location
Biogenea Pharmaceuticals Ltd
Learn More & Join Trial
Application of MRD Combined With Personalized Vaccine in the Treatment of Postoperative Recurrence Prevention of EOC PHASE2 The goal of this clinical trial is as follows:(1) Establish a clinical tech...
Show More Location
Second Affiliated Hospital of Wenzhou Medical University
Learn More & Join Trial
A DNAJB1-PRKACA Fusion Kinase Peptide Vaccine Combined With Glutamine Antagonist DRP-104, Nivolumab, and Ipilimumab in Patients With Advanced Stage Fibrolamellar Carcinoma (FLC) PHASE1 The purpose of this study is to determine whether the combination of a neoa...
Show More Location
Johns Hopkins SKCCC
Learn More & Join Trial
H3.3K27M Peptide Vaccine With Nivolumab for Children With Newly Diagnosed DIPG and Other Gliomas PHASE1 This is 3-arm, multicenter study that will be conducted through the Pacific...
Show More Location
Rady Children's Hospital-San Diego
Learn More & Join Trial
Safety and Immunogenicity of a Personalized Synthetic Long Peptide Breast Cancer Vaccine Strategy in Patients With Persistent Triple-Negative Breast Cancer Following Neoadjuvant Chemotherapy PHASE1 The most important consideration in the design of this clinical trial is to...
Show More Location
Multiple Locations
Learn More & Join Trial
KRAS-Targeted Vaccine With Chemoimmunotherapy, Nivolumab and Ipilimumab for Patients With NSCLC PHASE1 This is a single institution, Phase 1 study for patients with Stage III/IV ...
Show More Location
Johns Hopkins University
Learn More & Join Trial